| dc.contributor.author | Harding, D | en_US |
| dc.contributor.author | Fanti, S | en_US |
| dc.contributor.author | Marelli-Berg, F | en_US |
| dc.date.accessioned | 2024-02-27T11:53:04Z | |
| dc.date.issued | 2024-02-27 | en_US |
| dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/94929 | |
| dc.format.extent | 1 - 2 | en_US |
| dc.language | eng | en_US |
| dc.relation.ispartof | Cardiovasc Res | en_US |
| dc.rights | This is a pre-copyedited, author-produced version of an article accepted for publication in Cardiovascular Research following peer review. The version of record Daniel Harding, Silvia Fanti, Federica Marelli-Berg, Tumour necrosis factor-α in cardiac inflammation: friend or foe?, Cardiovascular Research, 2023;, cvad180, https://doi.org/10.1093/cvr/cvad180 is available online at: https://doi.org/10.1093/cvr/cvad180. | |
| dc.subject | Humans | en_US |
| dc.subject | Tumor Necrosis Factor-alpha | en_US |
| dc.subject | Myocarditis | en_US |
| dc.subject | CD4-Positive T-Lymphocytes | en_US |
| dc.subject | Arrhythmias, Cardiac | en_US |
| dc.subject | Inflammation | en_US |
| dc.subject | Death | en_US |
| dc.title | Tumour necrosis factor-α in cardiac inflammation: friend or foe? | en_US |
| dc.type | Article | |
| dc.rights.holder | © The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology. | |
| dc.identifier.doi | 10.1093/cvr/cvad180 | en_US |
| pubs.author-url | https://www.ncbi.nlm.nih.gov/pubmed/38059906 | en_US |
| pubs.issue | 1 | en_US |
| pubs.notes | Not known | en_US |
| pubs.publication-status | Published | en_US |
| pubs.volume | 120 | en_US |
| rioxxterms.funder | Default funder | en_US |
| rioxxterms.identifier.project | Default project | en_US |
